Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Westermark
Giampaolo Merlini

Showing results (321-330 of 587) with videos related to

Pageof 59
Sort By:
Arthritis and Rheumatism|October 1, 2004
First report of systemic reactive (AA) amyloidosis in a patient with the hyperimmunoglobulinemia D with periodic fever syndromeLaura Obici, Carlo Manno, Andrea Onetti Muda, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Severity and reversibility of cardiac dysfunction and residual concentration of amyloidogenic light chain predict overall survival of patients with AL amyloidosis who attain complete responseGiovanni Palladini, Paolo Milani, Marco Basset, et al.
Blood Advances|April 7, 2020
Daratumumab in light chain deposition disease: rapid and profound hematologic response preserves kidney functionPaolo Milani, Marco Basset, Paola Curci, et al.
Haematologica|June 29, 2023
Amyloidogenic light chains impair plasma cell survivalMarjorie Pick, Eyal Lebel, Sharona Elgavish, et al.
Biochimica Et Biophysica Acta|September 13, 2005
Proteomics of beta2-microglobulin amyloid fibrilsMonica Stoppini, Palma Mangione, Maria Monti, et al.
Annals of Hematology|September 10, 2008
Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomideGiovanni Palladini, Paola Russo, Francesca Lavatelli, et al.
Leukemia|July 7, 2018
Assay to rapidly screen for immunoglobulin light chain glycosylation: a potential path to earlier AL diagnosis for a subset of patientsSanjay Kumar, David Murray, Surendra Dasari, et al.
The Canadian Journal of Cardiology|May 4, 2012
Serum amyloid a and C-reactive protein independently predict the recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular functionAlessandra Barassi, Raffaele Pezzilli, Antonio M Morselli-Labate, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 10, 2002
A multicenter phase II trial of 4'-iodo-4'deoxydoxorubicin (IDOX) in primary amyloidosis (AL)Morie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Biochimica Et Biophysica Acta|January 11, 2011
A novel approach for the purification and proteomic analysis of pathogenic immunoglobulin free light chains from serumFrancesca Lavatelli, Francesca Brambilla, Veronica Valentini, et al.
Pageof 59

Showing results (321-330 of 587) with videos related to

Sort By:
Pageof 59
Arthritis and Rheumatism|October 1, 2004
First report of systemic reactive (AA) amyloidosis in a patient with the hyperimmunoglobulinemia D with periodic fever syndromeLaura Obici, Carlo Manno, Andrea Onetti Muda, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 25, 2017
Severity and reversibility of cardiac dysfunction and residual concentration of amyloidogenic light chain predict overall survival of patients with AL amyloidosis who attain complete responseGiovanni Palladini, Paolo Milani, Marco Basset, et al.
Blood Advances|April 7, 2020
Daratumumab in light chain deposition disease: rapid and profound hematologic response preserves kidney functionPaolo Milani, Marco Basset, Paola Curci, et al.
Haematologica|June 29, 2023
Amyloidogenic light chains impair plasma cell survivalMarjorie Pick, Eyal Lebel, Sharona Elgavish, et al.
Biochimica Et Biophysica Acta|September 13, 2005
Proteomics of beta2-microglobulin amyloid fibrilsMonica Stoppini, Palma Mangione, Maria Monti, et al.
Annals of Hematology|September 10, 2008
Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomideGiovanni Palladini, Paola Russo, Francesca Lavatelli, et al.
Leukemia|July 7, 2018
Assay to rapidly screen for immunoglobulin light chain glycosylation: a potential path to earlier AL diagnosis for a subset of patientsSanjay Kumar, David Murray, Surendra Dasari, et al.
The Canadian Journal of Cardiology|May 4, 2012
Serum amyloid a and C-reactive protein independently predict the recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular functionAlessandra Barassi, Raffaele Pezzilli, Antonio M Morselli-Labate, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 10, 2002
A multicenter phase II trial of 4'-iodo-4'deoxydoxorubicin (IDOX) in primary amyloidosis (AL)Morie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Biochimica Et Biophysica Acta|January 11, 2011
A novel approach for the purification and proteomic analysis of pathogenic immunoglobulin free light chains from serumFrancesca Lavatelli, Francesca Brambilla, Veronica Valentini, et al.
Pageof 59